Trillium Asset Management LLC Has $11 Million Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Trillium Asset Management LLC cut its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 4.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 113,747 shares of the medical instruments supplier’s stock after selling 4,853 shares during the quarter. Trillium Asset Management LLC’s holdings in Merit Medical Systems were worth $11,001,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Barclays PLC raised its holdings in Merit Medical Systems by 305.4% in the 3rd quarter. Barclays PLC now owns 112,727 shares of the medical instruments supplier’s stock valued at $11,142,000 after acquiring an additional 84,923 shares in the last quarter. EULAV Asset Management raised its holdings in Merit Medical Systems by 400.0% in the 4th quarter. EULAV Asset Management now owns 115,000 shares of the medical instruments supplier’s stock valued at $11,123,000 after acquiring an additional 92,000 shares in the last quarter. Fisher Asset Management LLC raised its holdings in Merit Medical Systems by 3.2% in the 3rd quarter. Fisher Asset Management LLC now owns 221,690 shares of the medical instruments supplier’s stock valued at $21,910,000 after acquiring an additional 6,837 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Merit Medical Systems by 85.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 575,946 shares of the medical instruments supplier’s stock valued at $56,921,000 after acquiring an additional 265,648 shares in the last quarter. Finally, AMI Asset Management Corp raised its holdings in Merit Medical Systems by 28.7% in the 4th quarter. AMI Asset Management Corp now owns 33,041 shares of the medical instruments supplier’s stock valued at $3,196,000 after acquiring an additional 7,367 shares in the last quarter. 99.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Merit Medical Systems news, insider Brian G. Lloyd sold 25,000 shares of the company’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $99.50, for a total value of $2,487,500.00. Following the sale, the insider now owns 38,993 shares in the company, valued at approximately $3,879,803.50. The trade was a 39.07 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Stephen C. Evans sold 5,000 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $105.31, for a total value of $526,550.00. Following the completion of the sale, the director now owns 4,657 shares in the company, valued at $490,428.67. This trade represents a 51.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 109,132 shares of company stock worth $11,139,521 in the last 90 days. Insiders own 3.70% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on MMSI shares. Raymond James boosted their price target on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Tuesday, December 31st. Piper Sandler reissued an “overweight” rating and set a $116.00 price target (up previously from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Canaccord Genuity Group lowered their price target on Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating for the company in a report on Wednesday, February 26th. Barrington Research lowered their price target on Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating for the company in a report on Wednesday, February 26th. Finally, Needham & Company LLC lowered their price target on Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating for the company in a report on Wednesday, February 26th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.78.

Merit Medical Systems Trading Down 0.7 %

Shares of MMSI stock opened at $99.95 on Wednesday. The firm has a market capitalization of $5.88 billion, a P/E ratio of 49.00, a P/E/G ratio of 2.34 and a beta of 0.91. Merit Medical Systems, Inc. has a twelve month low of $70.70 and a twelve month high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. The stock’s fifty day simple moving average is $103.69 and its 200 day simple moving average is $100.70.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.